drug · unknown
prabotulinumtoxin A
Phase 2updated 6mo agoby $AEON AEON Biopharma, Inc.🔗 ChEMBL
Phase 2community read0 votes
Unknown drug with a maximum clinical stage of Approval (across all indications), with an approval for skin aging and 2 investigational indications.
targets
Synaptosomal-associated protein 25
all catalysts(0)
nothing on the calendar yet
News(1)
- FDA admonishes Evolus for ‘false and misleading’ social media claimsThe US Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion (OPDP) has issued an untitled letter to Evolus for exaggerating efficacy claims for its drug Jeuveau (prabotulinumt…raps · 1mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that